Wells Fargo & Company Cuts Ionis Pharmaceuticals (NASDAQ:IONS) Price Target to $77.00
Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) had its target price lowered by Wells Fargo & Company from $82.00 to $77.00 in a research note released on Thursday morning,Benzinga reports. The brokerage currently has an overweight rating on the stock. IONS has been the subject of several other reports. Guggenheim cut their price target on Ionis […]
More Stories
Nuwellis (NASDAQ:NUWE) Issues Quarterly Earnings Results, Beats Estimates By $2.62 EPS
Nuwellis (NASDAQ:NUWE – Get Free Report) posted its quarterly earnings data on Monday. The company reported $1.74 EPS for the...
JPMorgan Global Select Equity ETF (NASDAQ:JGLO) Short Interest Update
JPMorgan Global Select Equity ETF (NASDAQ:JGLO – Get Free Report) was the target of a significant decline in short interest...
Short Interest in Lipella Pharmaceuticals Inc. (NASDAQ:LIPO) Decreases By 98.7%
Lipella Pharmaceuticals Inc. (NASDAQ:LIPO – Get Free Report) was the target of a large decline in short interest during the...
J. Alberto Arias Sells 18,926 Shares of Sierra Metals Inc. (TSE:SMT) Stock
Sierra Metals Inc. (TSE:SMT – Get Free Report) Director J. Alberto Arias sold 18,926 shares of the company’s stock in...
Michael Todd King Sells 1,500 Shares of PROG Holdings, Inc. (NYSE:PRG) Stock
PROG Holdings, Inc. (NYSE:PRG – Get Free Report) insider Michael Todd King sold 1,500 shares of the stock in a...
Angi (NASDAQ:ANGI) Announces Earnings Results
Angi (NASDAQ:ANGI – Get Free Report) posted its earnings results on Monday. The technology company reported $0.07 EPS for the...